The Michigan State Medical Society (MSMS) Foundation will present the 20th Annual Conference on Bioethics on November 12 at the Sheraton Ann Arbor Hotel. This conference will discuss ethical issues related to the pharmaceutical industry including drug shortages, drug pricing, access to drugs, and research/regulatory issues. Ethical Issues in the Pharmaceutical Industry: Current Controversies and Challenges will:
- Assess the value of oncology therapeutics;
- Discuss value-based treatment decision and ethical concerns of expensive drugs;
- Summarize the scope of unethical tactics and actions physicians may take; and,
- Identify ways in which the introduction of money into medical practice and research can create conflicts of interest and perverse financial incentives.
Additionally, Ethical Issues in the Pharmaceutical Industry: Current Controversies and Challenges will explain the concepts of exploitation and undue influence, examine strategies for prioritizing access to Hepatitis C drugs when resource constraints prevent access, and recognize and explain challenges the direct-to-consumer industry presents. During the meeting, experts will present research and network with colleagues. Program is planned for health care professionals by physicians. Ethical Issues in the Pharmaceutical Industry: Current Controversies and Challenges allows physician attendees to earn up to 7 AMA PRA Category 1 Credit(s)™ during this one-day event.
To register or for more information on the MSMS Foundation's Ethical Issues in the Pharmaceutical Industry: Current Controversies and Challenges conference, please visit http://msms.org/eo.
Statement of Accreditation: The Michigan State Medical Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement: The Michigan State Medical Society designates this live activity for a maximum of 5.0 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.